Some recent analyst ratings include

• 11/1/2019-
  Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by Maxim Group
• 10/31/2019-
  Agile Therapeutics Inc (NASDAQ:AGRX) gets upgraded to Outperform by William Blair
• 6/6/2019-
  Agile Therapeutics Inc (NASDAQ:AGRX) has coverage initiated with a Outperform rating and $5.00 price target
• 4/12/2019-
  Agile Therapeutics Inc (NASDAQ:AGRX) has coverage initiated with a Buy rating and $4.00 price target
• 1/11/2019-
  Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by HC Wainwright with a $4.00 price target
• 3/14/2018-
  Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by Noble Financial

• On 10/28/2019 Perceptive Advisors Llc, Major Shareholder, sold 3,815,349 with an average share price of $0.51 per share and the total transaction amounting to $1,945,827.99.
• On 8/6/2019 Perceptive Advisors Llc, Major Shareholder, bought 2,300,000 with an average share price of $0.95 per share and the total transaction amounting to $2,185,000.00.
• On 6/10/2019 Alfred Altomari, CEO, bought 20,000 with an average share price of $1.27 per share and the total transaction amounting to $25,400.00.
• On 3/29/2019 Abhijeet J Lele, Director, bought 20,000 with an average share price of $1.54 per share and the total transaction amounting to $30,800.00.
• On 3/25/2019 Alfred Altomari, CEO, bought 25,000 with an average share price of $1.54 per share and the total transaction amounting to $38,500.00.
• On 7/26/2018 Life Sciences Maste Perceptive, Insider, sold 298,628 with an average share price of $0.30 per share and the total transaction amounting to $89,588.40.
• On 8/25/2017 Alfred Altomari, Chairman, bought 10,000 with an average share price of $3.34 per share and the total transaction amounting to $33,400.00.

Recent Trading Activity for